Naveen Jain’s microbiome and diagnostics startup Viome is raising more cash
Seattle-area startup Viome Life Sciences secured $67 million in funding, increasing its total capital raise to over $125 million.
The company sells kits that determine the microbial composition of stool samples, recommending “precision” supplements and antibiotics based on the results. Additionally, the company is developing a diagnostic test for oral and throat cancer. This work received breakthrough device designation through the Federal Drug Administration in August.
It projected last year that it would hit $100 million in revenue in 2022. As of April 2021, it said it had over 200,000 customers.